MD Anderson study finds no association with assay and decreased
chemotherapy use in older patients
MD Anderson News Release 12/11/2014
In what’s believed to be one of the largest population-based studies
of Oncotype DX ever conducted, researchers at The University of Texas
MD Anderson Cancer Center have found that the commercial diagnostic
tool, Oncotype DX, was associated with a decrease in chemotherapy use...